Imugene
Imugene Logo
About Imugene
Imugene Ltd is a clinical-stage biotechnology company specializing in immuno-oncology therapies that activate the immune system to target and eradicate cancer. The company develops a pipeline of innovative treatments, including allogeneic CAR T cell therapies, oncolytic virotherapies, and B-cell immunotherapy cancer vaccines for a range of cancers such as lymphoma, leukemia, breast, gastric, lung, and colorectal cancers. Imugene's lead candidates include azer-cel, CF33 VAXINIA, HER-VAXX, PD1-Vaxx, and NeoPOLEM, with multiple products in phase 1 and 2 clinical trials. The company operates in Australia and Europe, collaborating with partners to advance cancer immunotherapies.
Address
4-6 Bligh Street, Suite 12.01, Level 12
Sydney, 2000
Australia
Year founded
2000
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
